EP
XENT

Eversept Partners’s Intersect ENT, Inc XENT Stock Holding History

Eversept Partners’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-175,389
Closed -$3M – 128
2021
Q2 		$3M Buy
175,389
+100,000
+133% +$1.87M 0.2% 59
2021
Q1 		$1.57M Buy
+75,389
New +$1.74M 0.12% 68

Other funds holding XENT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eversept Partners's XENT Position: Q3 2021 in Review

Eversept Partners sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 175,389 shares — an estimated $3M sold.

Eversept Partners first reported a position in XENT in Q1 2021 and held it in 2 quarters. The position peaked at $3M in Q2 2021. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Eversept Partners reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • Eversept Partners sold 175,389 Intersect ENT, Inc shares in Q3 2021, an estimated $3M.
  • Eversept Partners first reported a position in Intersect ENT, Inc in Q1 2021 and held it in 2 quarters.
  • Eversept Partners's Intersect ENT, Inc position peaked at $3M in Q2 2021.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Eversept Partners's 13F filing for Q3 2021, filed 15 Nov 2021.